Neurol. praxi. 2014;15(4):216-218

Churg-Strauss syndrome with a central neurological finding

MUDr. Jiří Pi»ha, MUDr. Marta Vachová, MUDr. Jana Kotalová, MUDr. Simona Vondráčková, MUDr. Markéta Ceé
MS Centrum Teplice, Neurologické oddělení KZ a.s. &ndash, Nemocnice Teplice o. z.

We report a case of a young female patient who presented with a monophasic multifocal neurological finding. The correct diagnosis was only determined based on differential diagnosis of multiple sclerosis. The subsequent course and clinical finding were indicative of Churg-Strauss syndrome, with four diagnostic criteria (bronchial asthma, nasal polyps, eosinophilia, and neurological symptomatology) being met. A dominant central neurological finding was unusual.

Keywords: clinically isolated syndrome, Churg-Strauss syndrome, vasculitides

Published: September 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pi»ha J, Vachová M, Kotalová J, Vondráčková S, Ceé M. Churg-Strauss syndrome with a central neurological finding. Neurol. praxi. 2014;15(4):216-218.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bosch X, Guilabert A, Espinosa G, Mirapeix E. JAMA. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. 2007; 298(6): 655-669.
    2. Gayraud M, Guillevin L, Cohen P, Lhote F, Cacoub P, Deblois P, Godeau B, Ruel M, Vidal E, Piontud M, Ducroix JP, Lassoued S, Christoforov B, Babinet P. French Cooperative Study Group for Vasculitides. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. Br J Rheumatol. 1997; 36(12): 1290-1297. Go to original source... Go to PubMed...
    3. Ghaeni L, SIebert E, Ostendorf F, Enders M, Reuter U. Multiple cerebral infactions in patiens witch Churg-Strauss syndrome. J Neurol 2010; 257: 678-680. Go to original source... Go to PubMed...
    4. Grau R.G. Churg-Strauss syndrome: 2005-2008 update. Curr Rheumatol Rep 2008; 10: 453-458. Go to original source... Go to PubMed...
    5. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.Medicine (Baltimore). 1996; 75(1): 17-28. Go to original source... Go to PubMed...
    6. Hervier B, Durant C, Masseau A, Ponge T, Hamidou M, Mussini JM. Use of muscle biopsies for diagnosis of systemic vasculitides. J Rheumatol 2011; 38(3): 470-474. Go to original source... Go to PubMed...
    7. Lane SE, Watts RA, Shepstone L, Scott DGI. Primary systemic vasculitis: clinical features and mortality. 2005; QJM 98: 97-111.
    8. Masi AT, Hunder CG, Lie JT, Michel BA, Bloch DA, Arend WP. The American College od Rheumatology kriteria for classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-1100. Go to original source... Go to PubMed...
    9. Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA and on behalf of the European Vasculitis Study Group (EUVAS). Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 2008; 67: 1004-1010. Go to original source... Go to PubMed...
    10. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69(2): 292-302. Go to original source... Go to PubMed...
    11. Ribi C, Cohen P, Pagnoux C, Mahr A, Ar?ne JP, Lauque D, Puéchal X, Letellier P, Delaval P, Cordier JF, Guillevin L. French Vasculitis Study Group. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum 2008; 58(2): 586-594. Go to original source... Go to PubMed...
    12. Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143: 632-638. Go to original source... Go to PubMed...
    13. Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995; 70: 337-341. Go to original source... Go to PubMed...
    14. Vaglio A, Martorana D, Maggiore U, Grasselli C, Zanetti A, Pesci A, Garini G, Manganelli P, Bottero P, Tumiati B, Sinico RA, Savi M, Buzio C, Neri TM. Secondary and Primary Vasculitis Study Group. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 2007; 56(9): 3159-3166. Go to original source... Go to PubMed...
    15. Winek J, Zych J, Wiatr E, Onoszh K, Rozskowski-Sliz K. Stroke as predominant symptom at Churg-Strauss syndrome. Pneumol Alergol 2007; 75: 191-196. Go to original source...
    16. Wolf J, Bergner R, Mutallib S, Buggle F, Grau ASJ. Neurologic complications of Churg-Strauss syndrome - a prospective monocentric study. Eur J Neurol 2010; 17: 582-588. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.